Business
KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES
KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT O...
About this update from Kda Group Inc.
[{"type":"text","content":"\n\n\nKDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\nCanada NewsWire\n\n\n\nTHETFORD MINES, QC, Dec. 1, 2025 /CNW/ - KDA Group Inc. (TSXV: KDA) (\"KDA\" or the \"Corporation\"), a leader in innovative technological solutions for healthcare professionals, is pleased to announce a major new phase in the national rollout of its Medherize platform. After deployment at the CHU de Québec, Hôpital du Saint-Sacrement, where nearly 200 patients are already being monitored through the application, Medherize is now being deployed in community pharmacies, including those affiliated with the Horizon Santé banner as well as in a pharmacy in Quebec City affiliated with the Jean Coutu banner. This marks a pivotal moment, as oncologists, patients, and now pharmacists are connected through a single digital platform that enables structured, continuous, and secure monitoring of oral anticancer treatments.\nFully aligned with the provincial framework for oral anticancer medications (\"OAMs\"). The Ministère de la Santé et des Services sociaux recently published a new framework aimed at optimizing community pharmacy practices for OAMs. It requires pharmacists to evaluate the patient's clinical status and analyze therapies using available lab results, provide complete patient counseling and follow-up planning, detect and manage treatment-related issues including adverse effects, and ensure continuity of care with other healthcare professionals.\nMedherize was specifically designed to support these obligations. With its arrival in community pharmacies, these establishments are now fully integrated into the digital ecosystem for oral therapy monitoring. The platform provides pharmacists with direct access to the therapeutic plan established by the oncologist and automatically retrieves, via the Dossier Santé Québec (DSQ), the patient's laboratory results, including electrocardiograms (ECGs).\nPharmacists can track patient-reporte...